Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker - Wikidata - wikimedia - TriplyDB

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker

http://www.wikidata.org/entity/Q28241095

about

Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.Emerging PSA-based tests to improve screening Kallikreins as biomarkers for prostate cancer Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues The emerging roles of human tissue kallikreins in cancer Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates.A combined approach to data mining of textual and structured data to identify cancer-related targets.Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology.Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer.Novel peptide inhibitors of human kallikrein 2.mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials.Human tissue kallikrein gene family: a rich source of novel disease biomarkers.High-grade prostatic intraepithelial neoplasia.The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6.A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2.Prostate cancer - a biomarker perspective.PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer.Cellular distribution of human tissue kallikreins: immunohistochemical localization.Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.Blood biomarkers for prostate cancer detection and prognosis.New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.The present and future of prostate cancer urine biomarkers.Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.Development of peptides specifically modulating the activity of KLK2 and KLK3.Prostate cancer: the need for biomarkers and new therapeutic targets.Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men Novel biomarkers for the detection of prostate cancer.Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.Targeting kallikrein-related peptidases in prostate cancer.Biomarkers in prostate cancer: new era and prospective.Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.KLK-targeted Therapies for Prostate Cancer.Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.

P2860

Q24673693-0F6EE103-78C6-4282-9787-DB36E24911E0 Q24815893-563CBFF2-0A3D-4BE4-B2BE-3B69E6AF9251 Q26828563-83433BC5-4D64-4D0C-B8BB-F765879CAA26 Q26862434-9ECA5082-C1E2-44A0-A820-BD7628BB3244 Q28206587-688DDF98-5D1E-42AB-BCF8-0F23DC19F21D Q28290701-7F5528E6-F9F2-426E-82A8-42F0DA069265 Q31036435-00857030-DB41-4FF1-B723-8AC735ED38A9 Q31049403-20F41F55-F10F-49AC-87CB-3520DCB52A1E Q31068008-EE11150C-B53E-40D0-8A69-336B96CDC59A Q31134380-959A90FC-318F-4BCD-AAAF-11885780979D Q33235991-03B5D66E-3B50-4D1B-A3F6-11B4DD29CA65 Q33513772-41B2D985-6385-4EA1-A4DB-5EEF94F3144D Q34119299-AB9FDFC3-972A-4FBD-A331-3512C0472497 Q34291962-F69070D7-49AA-475F-BE0F-9AE259C7FBAD Q34447102-03BEDB18-72F9-4850-970C-764B64515CBA Q35032198-E6AC2FC8-D9BB-4ABB-8133-F3A642BC58ED Q35675446-3C5488FB-FEC5-44C9-9F8D-2536AA9F4499 Q35785685-5E3473DD-0CF4-4D12-8C5F-51DFD014EB4F Q35861497-116BA65A-6221-4695-9639-FDAC0948AD8F Q35959942-9D996BE6-15B1-4347-A046-EDF2B2B4D3A5 Q35992814-50F49D77-3FDC-4140-90DA-0660079029CF Q35993261-3EA59934-0949-4F89-BE98-348EC7692363 Q36519359-BA2591F8-1EFC-48D7-887A-BAA185F9267B Q36730598-B86B7CF0-8F23-4186-8CCC-2BF98A7BFE7B Q36772249-619BDD4E-EFFC-4F9C-974A-2A7A963FC2AB Q36895818-2C15BB50-3184-4D34-8861-7DC2FC366B6C Q36973830-E542128A-56AA-423B-A06A-8A43696EDAE9 Q37007392-35464423-6A58-467A-A0AA-E4AABC0D8E87 Q37037804-8765C1DA-332E-4433-B411-2349691CC658 Q37216674-ACF26E11-059A-48B3-B3F0-F0B28F1A5AA6 Q37476043-B661ABF2-4A0C-455B-8997-2000196DC90D Q37619482-5DFF1383-711A-4D6C-86F3-E06615090577 Q37708174-32B1D959-DA4B-4DAB-BA63-692C11E26A27 Q37878470-26DD0D4C-2639-4482-A502-871A250FC6CD Q38191293-34718F63-F14F-4510-9335-4F15B3B5F821 Q38232466-AE5B1186-E184-4DA5-92FF-AEDCB050345B Q38760061-B58C8CE7-CB1F-4CE4-B307-B7AC1223EFB7 Q38967486-26D58AEE-BF8D-41BB-A9CB-39A9A01681E3 Q40736593-ABF75727-69F1-4C7F-8F99-F1D7B555EFF6 Q42151262-4837E64A-6C87-4F86-9FD7-F31E40C46288

P2860

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker

http://www.wikidata.org/entity/Q28241095

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@ast

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@en

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@nl

type

label

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@ast

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@en

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@nl

prefLabel

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@ast

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@en

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@nl

P1433

Q28241095-DB7BE722-A479-42EF-8C6A-48CE3F77F0E9

P1476

Q28241095-DCF9FBFC-4A88-4E49-8F53-08315A908520

P2093

Q28241095-264AD1C7-A952-40B4-8A35-C0389AF45367

Q28241095-69945D98-BF2A-40E5-B34E-02E2FA712930

Q28241095-74B7DB7A-2DC0-40DC-A772-FC7B907AFB59

Q28241095-9CFC1CA5-42F8-4C48-8414-11DD2A8EE48F

Q28241095-A99CD431-2AB7-4715-8C04-E0A3B14D2A3B

Q28241095-AF06A5C1-A047-4A44-8DCA-1113ADC9B443

Q28241095-C1AB149C-6EF2-439B-8E06-405F729F3660

Q28241095-D0450AAB-171D-4D0A-BD41-C196BF29EC22

Q28241095-F7B5243B-519C-4229-92A2-DBE60A7BCC95

P304

Q28241095-707DE324-597B-408E-99D1-9CD3D6BC0199

P31

Q28241095-B6B51AA2-7F32-40F8-8311-EF687CFA1EDD

P356

Q28241095-2DF425B0-6220-4C8C-B9DC-5EE8BE69B91A

P407

Q28241095-6C16B670-976D-4EB9-8F79-FB80B59149CD

P433

Q28241095-295D6191-71B3-4C1C-873A-9CD8A1E72F0C

P478

Q28241095-C4FBD1C7-13D1-48D7-9F1C-202B00C30B8A

P577

Q28241095-ED1CB09E-BEBF-43A2-B06C-FCAA86AFB7B3

P698

Q28241095-54867594-9347-4721-9EEB-4ECAE765DDC6

P921

Q28241095-B08996E9-268B-4684-A5E9-99756D12DD5C

P356

S0090-4295(97)00108-8

P1433

P1476

Human glandular kallikrein 2 ( ...... a novel prostate cancer marker

@en

P2093

A Pacelli

http://www.w3.org/2001/XMLSchema#string

C Y Young

http://www.w3.org/2001/XMLSchema#string

D G Bostwick

http://www.w3.org/2001/XMLSchema#string

D J Tindall

http://www.w3.org/2001/XMLSchema#string

G G Klee

http://www.w3.org/2001/XMLSchema#string

H G Rittenhouse

http://www.w3.org/2001/XMLSchema#string

M F Darson

http://www.w3.org/2001/XMLSchema#string

P Roche

http://www.w3.org/2001/XMLSchema#string

R L Wolfert

http://www.w3.org/2001/XMLSchema#string

P304

857-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0090-4295(97)00108-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

1997-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9187691

http://www.w3.org/2001/XMLSchema#string

P921